KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exelixis (EXEL) Liabilities and Shareholders Equity: 2010-2025

Historic Liabilities and Shareholders Equity for Exelixis (EXEL) over the last 15 years, with Oct 2025 value amounting to $2.8 billion.

  • Exelixis' Liabilities and Shareholders Equity fell 4.62% to $2.8 billion in Q4 2025 from the same period last year, while for Oct 2025 it was $11.3 billion, marking a year-over-year decrease of 1.68%. This contributed to the annual value of $2.9 billion for FY2025, which is 0.18% up from last year.
  • Latest data reveals that Exelixis reported Liabilities and Shareholders Equity of $2.8 billion as of Q4 2025, which was up 5.43% from $2.7 billion recorded in Q3 2025.
  • In the past 5 years, Exelixis' Liabilities and Shareholders Equity registered a high of $3.1 billion during Q1 2023, and its lowest value of $2.1 billion during Q1 2021.
  • Moreover, its 3-year median value for Liabilities and Shareholders Equity was $2.9 billion (2023), whereas its average is $2.9 billion.
  • As far as peak fluctuations go, Exelixis' Liabilities and Shareholders Equity grew by 22.41% in 2021, and later decreased by 11.75% in 2024.
  • Quarterly analysis of 5 years shows Exelixis' Liabilities and Shareholders Equity stood at $2.6 billion in 2021, then grew by 17.40% to $3.1 billion in 2022, then declined by 4.20% to $2.9 billion in 2023, then dropped by 0.56% to $3.0 billion in 2024, then fell by 4.62% to $2.8 billion in 2025.
  • Its Liabilities and Shareholders Equity was $2.8 billion in Q4 2025, compared to $2.7 billion in Q3 2025 and $2.8 billion in Q2 2025.